Organising Committee |
Chairman |
| Gerhard ECKER (University of Vienna, Vienna, Austria) |
Members |
| Gabriele COSTANTINO (University of Parma, Parma, Italy) |
| Anna LINUSSON (Umea University, Umea, Sweden) |
| David LLOYD (Trinity College Dublin, Dublin, Ireland) |
| Jordi MESTRES (IMIM and University Pompeu Fabra, Barcelona, Spain) |
| Tudor I. OPREA (University of New Mexico, Albuquerque, United States) |
| Vladimir POROIKOV (Institute of Biomedical Chemistry, Moscow, Russia) |
| Gisbert SCHNEIDER (ETH Zürich, Zurich, Switzerland) |
| Anna TSANTILI-KAKOULIDOU (University of Athens, Athens, Greece) |
Scientific Advisory Board |
Members |
| Dimitris AGRAFIOTIS (Johnson & Johnson Pharmaceutical R&D, Philadelphia, United States) |
| Esin AKI-YALCIN (Ankara University, Ankara, Turkey) |
| Michael BARNES (Open Innovation, Stevenage, United Kingdom) |
| Niklas BLOMBERG (Cambridgeshire, United Kingdom) |
| Scott BOYER (AstraZeneca, Södertälje, Sweden) |
| Soren BRUNAK (Technical University of Denmark, Kongens Lyngby, Denmark) |
| Andrea CAVALLI (University of Bologna and IIT, Bologna, Italy) |
| Hiroshi CHUMAN (University of Tokushima, Tokushima, Japan) |
| Mark CRONIN (Liverpool John Moores University, Liverpool, United Kingdom) |
| John DEARDEN C. (Liverpool John Moores University, Liverpool, United Kingdom) |
| Emilio Xavier ESPOSITO (exeResearch LLC, East Lansing, United States) |
| Kimito FUNATSU (University of Tokyo, Tokyo, Japan) |
| Johan GOTTFRIES (Astra Hässle AB, Göteborg, Sweden) |
| Eric HAAKSMA (Boehringer Ingelheim Austria, Wien, Austria) |
| Gerhard HESSLER (Frankfurt am Main, Germany) |
| Alexander HILLISCH (Bayer, Wuppertal, Germany) |
| Andrew HOPKINS (University of Dundee, Dundee, United Kingdom) |
| Edgar JACOBY (Novartis Institutes for BioMedical Research, Basel, Switzerland) |
| Ajay N JAIN (University of California, San Francisco, United States) |
| William L. JORGENSEN (Yale University, New Haven, United States) |
| Jan M. KRIEGL (Boehringer-Ingelheim, Biberach, Germany) |
| Hugo KUBINYI (University of Heidelberg, Weisenheim am Sand, Germany) |
| Luhua LAI (Peking University, Beijing, China) |
| Thierry LANGER (Prestwick Chemical, Vienna, Austria) |
| Andrew R. LEACH (AstraZeneca Pharmaceuticals, Stevenage, United Kingdom) |
| Paul LEESON (GlaxoSmithKline, United Kingdom) |
| David T MANALLACK (Monash University, Parkville, Australia) |
| Yvonne C. MARTIN (Martin Consulting, Waukegan, United States) |
| Anthony NICHOLLS (OpenEye Scientific Software, Santa Fe, United States) |
| Kyoung Tai NO (Yonsei University, Seoul, Korea, South) |
| Alessandro PADOVA (Siena Biotech, Siena, Italy) |
| Vladimir A. PALYULIN (M.V.Lomonosov Moscow State University, Moscow, Russia) |
| Matthias RAREY (University of Hambourg, Hamburg, Germany) |
| Ferran SANZ (University Pompeu Fabra, Barcelona, Spain) |
| Anil SAXENA (Central Drug Research Institute, Lucknow, India) |
| Klaus-Jürgen SCHLEIFER (Heinrich-Heine-Universität, Ludwigshafen, Germany) |
| Tanja SCHULZ-GASCH (F. Hoffmann-La Roche, Basel, Switzerland) |
| Brian SHOICHET (University of California San Francisco, Toronto, Canada) |
| Wolfgang SIPPL (Martin-Luther-Universität Halle-Wittenberg, Halle, Germany) |
| Alexander TROPSHA (University of North Carolina at Chapel Hill, Chapel Hill, United States) |
| Nico VERMEULEN (Leiden/Amsterdam Center for Drug Research, Amsterdam, The Netherlands) |
| Rebecca WADE (HITS, Heidelberg, Germany) |
| Renxiao WANG (Shanghai, China) |
| Anthony WILLIAMS (RSC - ChemSpider, Raleigh-Durham, United States) |
| Bryn I. WILLIAMS-JONES (Pfizer, Kent, United Kingdom) |
| David WINKLER (Csiro Molecular Science, Clayton South , Australia) |
| Ismail YALCIN (Ankara University, Ankara, Turkey) |